chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Ischaemic stroke, Transient ischaemic attack, Urinary tract infection
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA 5/30/2022 UTI (URINARY TRACT INFECTION) ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 5/30/2022 UTI (URINARY TRACT INFECTION) HYPOXIA 5/30/2022 UTI (URINARY TRACT INFECTION) TRANSIENT CEREBRAL ISCHEMIA 5/30/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 5/30/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY HYPOXIA 5/30/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 68.0
Sex: F
Vaccine: COVID19, TDAP, VARZOS
Symptoms: Incorrect product formulation administered
Clinical narrative: ADMINISTRATION ERROR: PATIENT WAS ELIGIBLE FOR BIVALENT COVID VACCINE BUT WAS ADMINISTERED NON-BIVALENT COVID VACCINE, FACILITY, PATIENT AND PRIMARY DOCTOR ARE BEING INFORMED. WILL FOLLOW UP TO SEE IF PATIENT/DOCTOR WANTS BIVALENT BOOSTER ADMINISTERED IN 2 MONTHS
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: HE WAS HER FOR A WELL EXAM
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Decreased appetite, Fatigue, Headache
Clinical narrative: I tested positive for COVID-19 on 2/27/23. I had a bad headache first, coughing, fatigue, runny nose, and loss of appetite. I contacted my doctor and was prescribed PAXLOVID, doxycycline hyclate, albuterol, and prednisone. I also took vitamin B12 and vitamin C. It took me about four weeks to get over the cough.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on 2/27/23. I had a bad headache first, coughing, fatigue, runny nose, and loss of appetite. I contacted my doctor and was prescribed PAXLOVID, doxycycline hyclate, albuterol, and prednisone. I also took vitamin B12 and vitamin C. It took me about four weeks to get over the cough.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain, Pain in extremity
Clinical narrative: Patient reports that 2 days after receiving her COVID vaccine her arm became very painful, and after 4 days she was unable to move it due to the pain.  She went to a chiropractor and message therapist which helped, but her upper arm continues to be extremely painful 3 weeks after receving the vaccine.  The pain is worse in the morning, and she has difficutly moving her arm due to the pain.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Chills, Cough, Exposure to SARS-CoV-2
Clinical narrative: I woke up and felt achy and had a headache and muscle aches. I had been at an event over the weekend and another person at the event said her husband tested positive for COVID-19, so I thought I had it too. I took a test on 03/21/23 and it was negative and then I had a positive result on 03/22/23. My symptoms got worse. I developed a cough, sore throat, fever, weakness, chilling, and flu like symptoms. The 22nd and 23rd of March were the worst but it started to gradually ease off. I had to take some time off that week. I called the doctor and the NP said to call if it got worse or wait if it did not. I had another test on 03/29/23 and it was positive, then another test on 03/30/23 and 03/31/23 and they came back negative.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Headache, Impaired work ability, Influenza like illness, Myalgia, Oropharyngeal pain
Clinical narrative: I woke up and felt achy and had a headache and muscle aches. I had been at an event over the weekend and another person at the event said her husband tested positive for COVID-19, so I thought I had it too. I took a test on 03/21/23 and it was negative and then I had a positive result on 03/22/23. My symptoms got worse. I developed a cough, sore throat, fever, weakness, chilling, and flu like symptoms. The 22nd and 23rd of March were the worst but it started to gradually ease off. I had to take some time off that week. I called the doctor and the NP said to call if it got worse or wait if it did not. I had another test on 03/29/23 and it was positive, then another test on 03/30/23 and 03/31/23 and they came back negative.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I woke up and felt achy and had a headache and muscle aches. I had been at an event over the weekend and another person at the event said her husband tested positive for COVID-19, so I thought I had it too. I took a test on 03/21/23 and it was negative and then I had a positive result on 03/22/23. My symptoms got worse. I developed a cough, sore throat, fever, weakness, chilling, and flu like symptoms. The 22nd and 23rd of March were the worst but it started to gradually ease off. I had to take some time off that week. I called the doctor and the NP said to call if it got worse or wait if it did not. I had another test on 03/29/23 and it was positive, then another test on 03/30/23 and 03/31/23 and they came back negative.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: WAS HERE FOR A WELL EXAM
Age: 11.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: no adverse reactions
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chemotherapy, Computerised tomogram normal, Cyst removal, Metastatic neoplasm
Clinical narrative: 12/11/2023 diagnosed with Metastatic Carcinoma. I recently had a Cyst removed from my back it was sent to Pathology and it was positive for Carcinoma I am currently in Chemotherapy indefinitely. They found 4 spots in my back, sternum and breast.
Age: 79.0
Sex: M
Vaccine: COVID19, PNC20
Symptoms: Incorrect product formulation administered
Clinical narrative: ADMINISTRATION ERROR: PATIENT WAS ELIGIBLE FOR BIVALENT COVID VACCINE BUT WAS ADMINISTERED NON-BIVALENT COVID VACCINE, FACILITY, PATIENT AND PRIMARY DOCTOR ARE BEING INFORMED. WILL FOLLOW UP TO SEE IF PATIENT/DOCTOR WANTS BIVALENT BOOSTER ADMINISTERED IN 2 MONTHS
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 4/8/2023 Discharge Date: 04/10/2023  Discharge Disposition: Home  PRESENTING PROBLEM: Diarrhea & weakness   HOSPITAL COURSE: Patient is a 86-year-old female who was admitted on 04/08/2023 for sepsis and questionable pneumonia, she was given Rocephin and azithromycin on 04/08, but no further doses as film array returned positive for COVID-19 infection.  Initially patient was also hypoxic down to 85% on room air and requiring 3 L, she has now been weaned to room air for 24 hours.  She was started on Decadron 6 mg daily for 2 doses, will not continue at discharge. Patient was thought to not be taking her Eliquis, as this had not been filled since September of 2022.  However patient states that Eliquis was not affordable and Cardiology was able to get her samples, she still has enough for 1.5 months.   Patient feels great and wants to go home.  Vitals are stable.  Medically clear for discharge.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Sepsis
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 4/8/2023 Discharge Date: 04/10/2023  Discharge Disposition: Home  PRESENTING PROBLEM: Diarrhea & weakness   HOSPITAL COURSE: Patient is a 86-year-old female who was admitted on 04/08/2023 for sepsis and questionable pneumonia, she was given Rocephin and azithromycin on 04/08, but no further doses as film array returned positive for COVID-19 infection.  Initially patient was also hypoxic down to 85% on room air and requiring 3 L, she has now been weaned to room air for 24 hours.  She was started on Decadron 6 mg daily for 2 doses, will not continue at discharge. Patient was thought to not be taking her Eliquis, as this had not been filled since September of 2022.  However patient states that Eliquis was not affordable and Cardiology was able to get her samples, she still has enough for 1.5 months.   Patient feels great and wants to go home.  Vitals are stable.  Medically clear for discharge.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Dyspnoea, Post-acute COVID-19 syndrome
Clinical narrative: 12/27/2022 I started experiencing shortness of breath, coughing. After reaching out to doctor I was diagnosed with Post Covid-19 conditions. I was prescribed Symbicort and Flonase.
Age: 66.0
Sex: F
Vaccine: SMALL
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Large red spot. Hot to touch. Growing. Raised.
Age: 76.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 4/7/2023 Discharge Date: Apr 9, 2023  PRESENTING PROBLEM: Chronic obstructive pulmonary disease, unspecified COPD type (HCC) COVID-19   HOSPITAL COURSE: 76-year-old male with a past medical history significant for diastolic congestive heart failure on Lasix at home as well as chronic obstructive pulmonary disease with home oxygen utilizing 2 L occasionally but not continuously who presents to the hospital with complaints of cough and shortness of breath.   In the emergency department patient is found to be tachycardic but normotensive.  Oxygen level is low and he required 4 L of oxygen to maintain adequate oxygen saturation.  Labs were obtained and remarkable for a white blood cell count of 10.84.  High sensitivity troponin I was elevated at 47 with repeat check found to be decreased at 39. NT proBNP was found to be 486, within normal limits.  Respiratory viral swab came back positive for COVID-19.  Chest x-ray was read as concerning for subsegmental atelectasis or pneumonia within the left mid lung field and left lung base.  Patient was given a dose of Lasix, methylprednisolone, DuoNebs, and thought to warrant admission to the hospital.   Patient fell much improved shortly after admission to the hospital.  He is continued on remdesivir as well as dexamethasone.  Oxygen was able to be weaned off.   By 4/9, patient was able to maintain adequate oxygen saturation while on room air and at rest.  With activity, patient did not significantly desaturate.  As the patient was feeling much better, he was allowed to be discharged home with prescription for 5 more days of oral dexamethasone and recommendation to continue with home oxygen with activity as he normally does.  He was discharged in stable condition on 04/09.
Age: 76.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Cough, Dyspnoea, Laboratory test abnormal, N-terminal prohormone brain natriuretic peptide increased, Oxygen saturation decreased
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 4/7/2023 Discharge Date: Apr 9, 2023  PRESENTING PROBLEM: Chronic obstructive pulmonary disease, unspecified COPD type (HCC) COVID-19   HOSPITAL COURSE: 76-year-old male with a past medical history significant for diastolic congestive heart failure on Lasix at home as well as chronic obstructive pulmonary disease with home oxygen utilizing 2 L occasionally but not continuously who presents to the hospital with complaints of cough and shortness of breath.   In the emergency department patient is found to be tachycardic but normotensive.  Oxygen level is low and he required 4 L of oxygen to maintain adequate oxygen saturation.  Labs were obtained and remarkable for a white blood cell count of 10.84.  High sensitivity troponin I was elevated at 47 with repeat check found to be decreased at 39. NT proBNP was found to be 486, within normal limits.  Respiratory viral swab came back positive for COVID-19.  Chest x-ray was read as concerning for subsegmental atelectasis or pneumonia within the left mid lung field and left lung base.  Patient was given a dose of Lasix, methylprednisolone, DuoNebs, and thought to warrant admission to the hospital.   Patient fell much improved shortly after admission to the hospital.  He is continued on remdesivir as well as dexamethasone.  Oxygen was able to be weaned off.   By 4/9, patient was able to maintain adequate oxygen saturation while on room air and at rest.  With activity, patient did not significantly desaturate.  As the patient was feeling much better, he was allowed to be discharged home with prescription for 5 more days of oral dexamethasone and recommendation to continue with home oxygen with activity as he normally does.  He was discharged in stable condition on 04/09.
Age: 76.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Pneumonia, Respiratory viral panel, SARS-CoV-2 test positive, Tachycardia, Troponin I
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 4/7/2023 Discharge Date: Apr 9, 2023  PRESENTING PROBLEM: Chronic obstructive pulmonary disease, unspecified COPD type (HCC) COVID-19   HOSPITAL COURSE: 76-year-old male with a past medical history significant for diastolic congestive heart failure on Lasix at home as well as chronic obstructive pulmonary disease with home oxygen utilizing 2 L occasionally but not continuously who presents to the hospital with complaints of cough and shortness of breath.   In the emergency department patient is found to be tachycardic but normotensive.  Oxygen level is low and he required 4 L of oxygen to maintain adequate oxygen saturation.  Labs were obtained and remarkable for a white blood cell count of 10.84.  High sensitivity troponin I was elevated at 47 with repeat check found to be decreased at 39. NT proBNP was found to be 486, within normal limits.  Respiratory viral swab came back positive for COVID-19.  Chest x-ray was read as concerning for subsegmental atelectasis or pneumonia within the left mid lung field and left lung base.  Patient was given a dose of Lasix, methylprednisolone, DuoNebs, and thought to warrant admission to the hospital.   Patient fell much improved shortly after admission to the hospital.  He is continued on remdesivir as well as dexamethasone.  Oxygen was able to be weaned off.   By 4/9, patient was able to maintain adequate oxygen saturation while on room air and at rest.  With activity, patient did not significantly desaturate.  As the patient was feeling much better, he was allowed to be discharged home with prescription for 5 more days of oral dexamethasone and recommendation to continue with home oxygen with activity as he normally does.  He was discharged in stable condition on 04/09.
Age: 76.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Troponin increased, White blood cell count increased
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 4/7/2023 Discharge Date: Apr 9, 2023  PRESENTING PROBLEM: Chronic obstructive pulmonary disease, unspecified COPD type (HCC) COVID-19   HOSPITAL COURSE: 76-year-old male with a past medical history significant for diastolic congestive heart failure on Lasix at home as well as chronic obstructive pulmonary disease with home oxygen utilizing 2 L occasionally but not continuously who presents to the hospital with complaints of cough and shortness of breath.   In the emergency department patient is found to be tachycardic but normotensive.  Oxygen level is low and he required 4 L of oxygen to maintain adequate oxygen saturation.  Labs were obtained and remarkable for a white blood cell count of 10.84.  High sensitivity troponin I was elevated at 47 with repeat check found to be decreased at 39. NT proBNP was found to be 486, within normal limits.  Respiratory viral swab came back positive for COVID-19.  Chest x-ray was read as concerning for subsegmental atelectasis or pneumonia within the left mid lung field and left lung base.  Patient was given a dose of Lasix, methylprednisolone, DuoNebs, and thought to warrant admission to the hospital.   Patient fell much improved shortly after admission to the hospital.  He is continued on remdesivir as well as dexamethasone.  Oxygen was able to be weaned off.   By 4/9, patient was able to maintain adequate oxygen saturation while on room air and at rest.  With activity, patient did not significantly desaturate.  As the patient was feeling much better, he was allowed to be discharged home with prescription for 5 more days of oral dexamethasone and recommendation to continue with home oxygen with activity as he normally does.  He was discharged in stable condition on 04/09.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 4/5/2023 Discharge Date: 4/10/2023  PRESENTING PROBLEM: Respiratory infection Sepsis due to pneumonia Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID Sepsis   HOSPITAL COURSE:    Patient is a 61 y.o. male with prior medical history of progressive MS, chronic pain, depression, GERD, OSA who presented to hospital on 4/5/2023 with progressive weakness and fatigue.  The patient was found to be have Sepsis and COVID-19 positive upon arrival to the emergency department.  Initial chest x-ray performed in the emergency department showed concern for right axillary mass however CT of the chest did not visualize in the right axillary mass or lymph node enlargement.  Was noted to have mild left and right basilar streaky ground-glass opacities.  He received an initial dose of azithromycin and ceftriaxone and was monitored off for 24 hours.  Due to no leukocytosis or elevation of procalcitonin.  The patient then developed elevated fevers and an elevated procalcitonin and leukocytosis on 04/07/2023 and the antibiotics were resumed due to post-viral community acquired pneumonia.  While hospitalized he completed a 5 day course of azithromycin and ceftriaxone.  He also received 5 days of remdesivir. He will be discharging home with continued home health care services.  Discharge doing with the Mucinex as well as p.r.n. albuterol inhaler.  Due to myalgias he was also given a 3 day script for Norco as this has been helping with the symptom control.  Recommend post hospitalization follow-up with PCP in 1 week.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Leukocytosis, Lung opacity, Myalgia, Pneumonia
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 4/5/2023 Discharge Date: 4/10/2023  PRESENTING PROBLEM: Respiratory infection Sepsis due to pneumonia Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID Sepsis   HOSPITAL COURSE:    Patient is a 61 y.o. male with prior medical history of progressive MS, chronic pain, depression, GERD, OSA who presented to hospital on 4/5/2023 with progressive weakness and fatigue.  The patient was found to be have Sepsis and COVID-19 positive upon arrival to the emergency department.  Initial chest x-ray performed in the emergency department showed concern for right axillary mass however CT of the chest did not visualize in the right axillary mass or lymph node enlargement.  Was noted to have mild left and right basilar streaky ground-glass opacities.  He received an initial dose of azithromycin and ceftriaxone and was monitored off for 24 hours.  Due to no leukocytosis or elevation of procalcitonin.  The patient then developed elevated fevers and an elevated procalcitonin and leukocytosis on 04/07/2023 and the antibiotics were resumed due to post-viral community acquired pneumonia.  While hospitalized he completed a 5 day course of azithromycin and ceftriaxone.  He also received 5 days of remdesivir. He will be discharging home with continued home health care services.  Discharge doing with the Mucinex as well as p.r.n. albuterol inhaler.  Due to myalgias he was also given a 3 day script for Norco as this has been helping with the symptom control.  Recommend post hospitalization follow-up with PCP in 1 week.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin increased, Pyrexia, Respiratory tract infection, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 4/5/2023 Discharge Date: 4/10/2023  PRESENTING PROBLEM: Respiratory infection Sepsis due to pneumonia Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID Sepsis   HOSPITAL COURSE:    Patient is a 61 y.o. male with prior medical history of progressive MS, chronic pain, depression, GERD, OSA who presented to hospital on 4/5/2023 with progressive weakness and fatigue.  The patient was found to be have Sepsis and COVID-19 positive upon arrival to the emergency department.  Initial chest x-ray performed in the emergency department showed concern for right axillary mass however CT of the chest did not visualize in the right axillary mass or lymph node enlargement.  Was noted to have mild left and right basilar streaky ground-glass opacities.  He received an initial dose of azithromycin and ceftriaxone and was monitored off for 24 hours.  Due to no leukocytosis or elevation of procalcitonin.  The patient then developed elevated fevers and an elevated procalcitonin and leukocytosis on 04/07/2023 and the antibiotics were resumed due to post-viral community acquired pneumonia.  While hospitalized he completed a 5 day course of azithromycin and ceftriaxone.  He also received 5 days of remdesivir. He will be discharging home with continued home health care services.  Discharge doing with the Mucinex as well as p.r.n. albuterol inhaler.  Due to myalgias he was also given a 3 day script for Norco as this has been helping with the symptom control.  Recommend post hospitalization follow-up with PCP in 1 week.
Age: 14.0
Sex: F
Vaccine: HEP
Symptoms: Rash, Rash pruritic
Clinical narrative: Pt mother stated pt had an itchy rash the following day after vaccination. Pt described rash as itchy and all over her arms, legs, and torso. that lasted 3 days. Mother stated she gave pt an ointment but could not describe what it was.  Mother did not seek treatment and stated the rash went away after 3 days.
Age: 68.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Blister, COVID-19, Gait inability, Malaise, SARS-CoV-2 test positive
Clinical narrative: After a few days of testing negative on at home COVID-19 tests, I developed purple blisters on feet making walking impossible. I got a PCR test positive after blisters. Televisit with doctor who advised to treat symptomatically. Apart from blisters, the symptoms were just normal allergy symptoms. Sought dermatologist about the blisters. Dermatologist advised this was not Covid-Toe, provided some creams that cleared up the blisters. Creams included betamethasone dipropionate; clobetasol propionate; and ketoconazole.
Age: 68.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Skin discolouration
Clinical narrative: After a few days of testing negative on at home COVID-19 tests, I developed purple blisters on feet making walking impossible. I got a PCR test positive after blisters. Televisit with doctor who advised to treat symptomatically. Apart from blisters, the symptoms were just normal allergy symptoms. Sought dermatologist about the blisters. Dermatologist advised this was not Covid-Toe, provided some creams that cleared up the blisters. Creams included betamethasone dipropionate; clobetasol propionate; and ketoconazole.
Age: 57.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site pain, Mobility decreased, Tenderness
Clinical narrative: Pain of left shoulder, limited mobility, tender to the touch.
Age: 91.0
Sex: F
Vaccine: COVID19, TDAP, VARZOS
Symptoms: Incorrect product formulation administered, Product administration error
Clinical narrative: ADMINISTRATION ERROR: PATIENT WAS ELIGIBLE FOR BIVALENT COVID VACCINE BUT WAS ADMINISTERED NON-BIVALENT COVID VACCINE, FACILITY, PATIENT AND PRIMARY DOCTOR ARE BEING INFORMED. WILL FOLLOW UP TO SEE IF PATIENT/DOCTOR WANTS BIVALENT BOOSTER ADMINISTERED IN 2 MONTHS
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, COVID-19, Chest X-ray, Malaise, Post-acute COVID-19 syndrome
Clinical narrative: Got sick with Covid on 2/24/2023.  Did have a positive PCR test. I got over this in about a week. Then in April 2023, became sick and was diagnosed with Long Covid.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Got sick with Covid on 2/24/2023.  Did have a positive PCR test. I got over this in about a week. Then in April 2023, became sick and was diagnosed with Long Covid.
Age: 55.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Antiviral treatment, Blister, Cellulitis, Facial pain, Headache
Clinical narrative: PATIENT RECEIVED SHINGRIX AND PREVNAR VACCINES IN PRIMARY CARE OFFICE ON 3/24/2023. PATIENT REPORTS NOTICING ARM PAIN ON 3.25.2023. ON 3.29.2023 PATIENT WAS SEEN AGAIN IN THE OFFICE WITH C/O RIGHT DELTOID PAIN, WARMTH, AND REDNESS. PATIENT WAS DIAGNOSED WITH CELLULITIS AND PRESCRIBED DOXYCYCLINE PO, PREDNISONE PO, AND TRIAMCINOLONE CREAM. ON 4/4/2023 WAS SEEN AGAIN IN THE OFFICE WITH PAINFUL BLISTERS IN HER MOUTH & ALONG THE TRIGEMINAL DERMATOME ON HER RIGHT SIDE, HEAD & BODY ACHES. SHE WAS STARTED ON ORAL ACYCLOVIR & CONTINUED ORAL PREDNISONE. ON 4/6/2023 SHE WAS SEEN AGAIN IN THE OFFICE & THE RASH WAS NOTED TOBE SPREAD/FAILING ORAL ACYCLOVIR. THE PATIENT WAS ADVISED TO PRESENT TO THE HOSPITAL EMERGENCY DEPARTMENT, WHERE SHE WAS ADMITTED ON 4/6/2023 FOR IV ANTIVIRAL THERAPY. SHE WAS TREATED WITH IV ACYCLOVIR, PREDNISONE EAR DROPS, TRIAMCINOLONE CREAM, AND CONTINUED ORAL PREDNISONE. HER LESIONS IMPROVED AND SHE WAS DISCHARGED HOME IN GOOD CONDITION ON 4/8/2023. SHE WAS SEEN AGAIN IN THE PCP OFFICE ON 4/13/2023 WHERE IT WAS NOTED HER LESIONS WERE HEALING. PATIENT CONTINUES TO ? HEADACHE AND RASH ITCHINESS ON 4/13/2023.
Age: 55.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Oral mucosal blistering, Oral pain
Clinical narrative: PATIENT RECEIVED SHINGRIX AND PREVNAR VACCINES IN PRIMARY CARE OFFICE ON 3/24/2023. PATIENT REPORTS NOTICING ARM PAIN ON 3.25.2023. ON 3.29.2023 PATIENT WAS SEEN AGAIN IN THE OFFICE WITH C/O RIGHT DELTOID PAIN, WARMTH, AND REDNESS. PATIENT WAS DIAGNOSED WITH CELLULITIS AND PRESCRIBED DOXYCYCLINE PO, PREDNISONE PO, AND TRIAMCINOLONE CREAM. ON 4/4/2023 WAS SEEN AGAIN IN THE OFFICE WITH PAINFUL BLISTERS IN HER MOUTH & ALONG THE TRIGEMINAL DERMATOME ON HER RIGHT SIDE, HEAD & BODY ACHES. SHE WAS STARTED ON ORAL ACYCLOVIR & CONTINUED ORAL PREDNISONE. ON 4/6/2023 SHE WAS SEEN AGAIN IN THE OFFICE & THE RASH WAS NOTED TOBE SPREAD/FAILING ORAL ACYCLOVIR. THE PATIENT WAS ADVISED TO PRESENT TO THE HOSPITAL EMERGENCY DEPARTMENT, WHERE SHE WAS ADMITTED ON 4/6/2023 FOR IV ANTIVIRAL THERAPY. SHE WAS TREATED WITH IV ACYCLOVIR, PREDNISONE EAR DROPS, TRIAMCINOLONE CREAM, AND CONTINUED ORAL PREDNISONE. HER LESIONS IMPROVED AND SHE WAS DISCHARGED HOME IN GOOD CONDITION ON 4/8/2023. SHE WAS SEEN AGAIN IN THE PCP OFFICE ON 4/13/2023 WHERE IT WAS NOTED HER LESIONS WERE HEALING. PATIENT CONTINUES TO ? HEADACHE AND RASH ITCHINESS ON 4/13/2023.
Age: 55.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Pain, Pain in extremity, Rash pruritic, Skin lesion
Clinical narrative: PATIENT RECEIVED SHINGRIX AND PREVNAR VACCINES IN PRIMARY CARE OFFICE ON 3/24/2023. PATIENT REPORTS NOTICING ARM PAIN ON 3.25.2023. ON 3.29.2023 PATIENT WAS SEEN AGAIN IN THE OFFICE WITH C/O RIGHT DELTOID PAIN, WARMTH, AND REDNESS. PATIENT WAS DIAGNOSED WITH CELLULITIS AND PRESCRIBED DOXYCYCLINE PO, PREDNISONE PO, AND TRIAMCINOLONE CREAM. ON 4/4/2023 WAS SEEN AGAIN IN THE OFFICE WITH PAINFUL BLISTERS IN HER MOUTH & ALONG THE TRIGEMINAL DERMATOME ON HER RIGHT SIDE, HEAD & BODY ACHES. SHE WAS STARTED ON ORAL ACYCLOVIR & CONTINUED ORAL PREDNISONE. ON 4/6/2023 SHE WAS SEEN AGAIN IN THE OFFICE & THE RASH WAS NOTED TOBE SPREAD/FAILING ORAL ACYCLOVIR. THE PATIENT WAS ADVISED TO PRESENT TO THE HOSPITAL EMERGENCY DEPARTMENT, WHERE SHE WAS ADMITTED ON 4/6/2023 FOR IV ANTIVIRAL THERAPY. SHE WAS TREATED WITH IV ACYCLOVIR, PREDNISONE EAR DROPS, TRIAMCINOLONE CREAM, AND CONTINUED ORAL PREDNISONE. HER LESIONS IMPROVED AND SHE WAS DISCHARGED HOME IN GOOD CONDITION ON 4/8/2023. SHE WAS SEEN AGAIN IN THE PCP OFFICE ON 4/13/2023 WHERE IT WAS NOTED HER LESIONS WERE HEALING. PATIENT CONTINUES TO ? HEADACHE AND RASH ITCHINESS ON 4/13/2023.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: It appears this patient has received a 3rd bivalent booster dose almost a month after receiving a 2nd bivalent booster dose.
Age: 17.0
Sex: M
Vaccine: HEP, MMR
Symptoms: Wrong product administered
Clinical narrative: I administered Hep B Lot C44K4 1.0mL instead of a hep B pediatric 0.5mL at 6:55pm on April 12, 2023. Pt parents , Supervisor, PCP, and state notified.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: I tested positive for COVID -19 on February 11,2023. My symptoms were a cough, muscle ache, sore throat and I was prescribe paxlovid. I also had a slight temperature. I have a persistent cough.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID -19 on February 11,2023. My symptoms were a cough, muscle ache, sore throat and I was prescribe paxlovid. I also had a slight temperature. I have a persistent cough.
Age: 97.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Acute kidney injury, Acute respiratory failure, Angiogram pulmonary abnormal, Asthenia, Brain natriuretic peptide increased
Clinical narrative: Discharge Provider: Primary Care Physician at Discharge: DO Admission Date: 4/9/2023  PRESENTING PROBLEM: Shortness of breath [R06.02] Hypoxia [R09.02] AKI (acute kidney injury) [N17.9] Elevated brain natriuretic peptide (BNP) level [R79.89] Multifocal pneumonia [J18.9] Sepsis with acute hypoxic respiratory failure and septic shock, due to unspecified organism [A41.9, R65.21, J96.01] COVID-19 [U07.1] Acute respiratory failure [J96.00] Acute respiratory failure with hypoxemia [J96.01]   HOSPITAL COURSE: Patient is a 97 year old with extensive past medical history most significant for CAD, CKD, peripheral vascular disease, MR, hypertension with recent admission from 4/4-4/7 for weakness and near-syncope, diagnosed and treated for Ecoli UTI and diagnosed with COVID-19 on 4/4; presented to hospital ED 4/9 afternoon with dyspnea and lethargy.  CXR and CTA with marked bilateral infiltrates suspicious for progression of COVID-19 pneumonia with possible bacterial pneumonia.  Hypoxemic requiring HFNC 100%/55LPM.  AKI on arrival.  Discussion with patient's family established DNR/DNI status.  Also developed hypotension and started on peripheral Norepi.  She was admitted to MICU for ongoing management.  Extensive conversations between providers and family detailed the severity of her illness and comorbidities likely to prevent recovery though continuing aggressive care to establish trajectory.  By 4/10AM, off Norepi but still requiring HFNC 95%/55LPM with NRBM to maintain SpO2.  AKI worsening. Noted worsening of oxygen needs with frequent desaturations 4/11. Family and DPOA at bedside - decision made to transition to comfort measures.    Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria
Age: 97.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Dyspnoea, Escherichia urinary tract infection
Clinical narrative: Discharge Provider: Primary Care Physician at Discharge: DO Admission Date: 4/9/2023  PRESENTING PROBLEM: Shortness of breath [R06.02] Hypoxia [R09.02] AKI (acute kidney injury) [N17.9] Elevated brain natriuretic peptide (BNP) level [R79.89] Multifocal pneumonia [J18.9] Sepsis with acute hypoxic respiratory failure and septic shock, due to unspecified organism [A41.9, R65.21, J96.01] COVID-19 [U07.1] Acute respiratory failure [J96.00] Acute respiratory failure with hypoxemia [J96.01]   HOSPITAL COURSE: Patient is a 97 year old with extensive past medical history most significant for CAD, CKD, peripheral vascular disease, MR, hypertension with recent admission from 4/4-4/7 for weakness and near-syncope, diagnosed and treated for Ecoli UTI and diagnosed with COVID-19 on 4/4; presented to hospital ED 4/9 afternoon with dyspnea and lethargy.  CXR and CTA with marked bilateral infiltrates suspicious for progression of COVID-19 pneumonia with possible bacterial pneumonia.  Hypoxemic requiring HFNC 100%/55LPM.  AKI on arrival.  Discussion with patient's family established DNR/DNI status.  Also developed hypotension and started on peripheral Norepi.  She was admitted to MICU for ongoing management.  Extensive conversations between providers and family detailed the severity of her illness and comorbidities likely to prevent recovery though continuing aggressive care to establish trajectory.  By 4/10AM, off Norepi but still requiring HFNC 95%/55LPM with NRBM to maintain SpO2.  AKI worsening. Noted worsening of oxygen needs with frequent desaturations 4/11. Family and DPOA at bedside - decision made to transition to comfort measures.    Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria
Age: 97.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Hypotension, Hypoxia, Illness, Intensive care, Lethargy
Clinical narrative: Discharge Provider: Primary Care Physician at Discharge: DO Admission Date: 4/9/2023  PRESENTING PROBLEM: Shortness of breath [R06.02] Hypoxia [R09.02] AKI (acute kidney injury) [N17.9] Elevated brain natriuretic peptide (BNP) level [R79.89] Multifocal pneumonia [J18.9] Sepsis with acute hypoxic respiratory failure and septic shock, due to unspecified organism [A41.9, R65.21, J96.01] COVID-19 [U07.1] Acute respiratory failure [J96.00] Acute respiratory failure with hypoxemia [J96.01]   HOSPITAL COURSE: Patient is a 97 year old with extensive past medical history most significant for CAD, CKD, peripheral vascular disease, MR, hypertension with recent admission from 4/4-4/7 for weakness and near-syncope, diagnosed and treated for Ecoli UTI and diagnosed with COVID-19 on 4/4; presented to hospital ED 4/9 afternoon with dyspnea and lethargy.  CXR and CTA with marked bilateral infiltrates suspicious for progression of COVID-19 pneumonia with possible bacterial pneumonia.  Hypoxemic requiring HFNC 100%/55LPM.  AKI on arrival.  Discussion with patient's family established DNR/DNI status.  Also developed hypotension and started on peripheral Norepi.  She was admitted to MICU for ongoing management.  Extensive conversations between providers and family detailed the severity of her illness and comorbidities likely to prevent recovery though continuing aggressive care to establish trajectory.  By 4/10AM, off Norepi but still requiring HFNC 95%/55LPM with NRBM to maintain SpO2.  AKI worsening. Noted worsening of oxygen needs with frequent desaturations 4/11. Family and DPOA at bedside - decision made to transition to comfort measures.    Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria
Age: 97.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Lung infiltration, Oxygen saturation decreased, Pneumonia, Presyncope, Sepsis
Clinical narrative: Discharge Provider: Primary Care Physician at Discharge: DO Admission Date: 4/9/2023  PRESENTING PROBLEM: Shortness of breath [R06.02] Hypoxia [R09.02] AKI (acute kidney injury) [N17.9] Elevated brain natriuretic peptide (BNP) level [R79.89] Multifocal pneumonia [J18.9] Sepsis with acute hypoxic respiratory failure and septic shock, due to unspecified organism [A41.9, R65.21, J96.01] COVID-19 [U07.1] Acute respiratory failure [J96.00] Acute respiratory failure with hypoxemia [J96.01]   HOSPITAL COURSE: Patient is a 97 year old with extensive past medical history most significant for CAD, CKD, peripheral vascular disease, MR, hypertension with recent admission from 4/4-4/7 for weakness and near-syncope, diagnosed and treated for Ecoli UTI and diagnosed with COVID-19 on 4/4; presented to hospital ED 4/9 afternoon with dyspnea and lethargy.  CXR and CTA with marked bilateral infiltrates suspicious for progression of COVID-19 pneumonia with possible bacterial pneumonia.  Hypoxemic requiring HFNC 100%/55LPM.  AKI on arrival.  Discussion with patient's family established DNR/DNI status.  Also developed hypotension and started on peripheral Norepi.  She was admitted to MICU for ongoing management.  Extensive conversations between providers and family detailed the severity of her illness and comorbidities likely to prevent recovery though continuing aggressive care to establish trajectory.  By 4/10AM, off Norepi but still requiring HFNC 95%/55LPM with NRBM to maintain SpO2.  AKI worsening. Noted worsening of oxygen needs with frequent desaturations 4/11. Family and DPOA at bedside - decision made to transition to comfort measures.    Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria
Age: 97.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Septic shock
Clinical narrative: Discharge Provider: Primary Care Physician at Discharge: DO Admission Date: 4/9/2023  PRESENTING PROBLEM: Shortness of breath [R06.02] Hypoxia [R09.02] AKI (acute kidney injury) [N17.9] Elevated brain natriuretic peptide (BNP) level [R79.89] Multifocal pneumonia [J18.9] Sepsis with acute hypoxic respiratory failure and septic shock, due to unspecified organism [A41.9, R65.21, J96.01] COVID-19 [U07.1] Acute respiratory failure [J96.00] Acute respiratory failure with hypoxemia [J96.01]   HOSPITAL COURSE: Patient is a 97 year old with extensive past medical history most significant for CAD, CKD, peripheral vascular disease, MR, hypertension with recent admission from 4/4-4/7 for weakness and near-syncope, diagnosed and treated for Ecoli UTI and diagnosed with COVID-19 on 4/4; presented to hospital ED 4/9 afternoon with dyspnea and lethargy.  CXR and CTA with marked bilateral infiltrates suspicious for progression of COVID-19 pneumonia with possible bacterial pneumonia.  Hypoxemic requiring HFNC 100%/55LPM.  AKI on arrival.  Discussion with patient's family established DNR/DNI status.  Also developed hypotension and started on peripheral Norepi.  She was admitted to MICU for ongoing management.  Extensive conversations between providers and family detailed the severity of her illness and comorbidities likely to prevent recovery though continuing aggressive care to establish trajectory.  By 4/10AM, off Norepi but still requiring HFNC 95%/55LPM with NRBM to maintain SpO2.  AKI worsening. Noted worsening of oxygen needs with frequent desaturations 4/11. Family and DPOA at bedside - decision made to transition to comfort measures.    Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I got COVID-19 on March 13th, 2023. I had a scratchy throat, runny nose, then it turned into a very painful sore throat, no temperature. I tested with a home test kit on the 15th and I was positive. Ordinarily when I start to get a cold, I take cold ease with zinc. It wasn't helping my symptoms. I called my doctor and he prescribed PAXLOVID. I still have a bit of drainage in my nose, but I started taking better on the 17th and 18th. At the end of the five days, I was still positive. I was told to continue to stay indoors. I was negative five days after that on March 24th, 2023. I was feeling much better. I really didn't have the cough I have now, it's a like drainage still in my throat. I'm not congested just strain in my throat and time to time coughing.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: I got COVID-19 on March 13th, 2023. I had a scratchy throat, runny nose, then it turned into a very painful sore throat, no temperature. I tested with a home test kit on the 15th and I was positive. Ordinarily when I start to get a cold, I take cold ease with zinc. It wasn't helping my symptoms. I called my doctor and he prescribed PAXLOVID. I still have a bit of drainage in my nose, but I started taking better on the 17th and 18th. At the end of the five days, I was still positive. I was told to continue to stay indoors. I was negative five days after that on March 24th, 2023. I was feeling much better. I really didn't have the cough I have now, it's a like drainage still in my throat. I'm not congested just strain in my throat and time to time coughing.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: My COVID experience started out as a normal headache which lasted the entire time that than became a very bad headache. I also had some body aches and chills.
Age: 69.0
Sex: M
Vaccine: PNC15
Symptoms: Feeling abnormal, Pain in extremity, Peripheral swelling, Rash
Clinical narrative: Pt called stating they have not been feeling like themselves. States arm pain is still there and has rashes and swelling down to the elbow. Has been using Tylenol and ibuprofen. Symptoms have been worsening daily. Was referred to see doctor. If doctor is not available to go to urgent care as symptoms are continuing to worsen. Pt does not take an allergy pill regularly, was recommend Benadryl if an allergic reaction but better to follow up with doctor.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, Malaise, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 from my husband after a vacation with my family. I tested positive for COVID-19 on 04/02/2023. I contacted my provider and got a prescription for Paxlovid. I tolerated the medication without any complications. As a result of being sick, I lost 8 pounds. As of today, I am feeling better, but I am feeling tired and require a nap.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Somnolence, Weight decreased
Clinical narrative: I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 from my husband after a vacation with my family. I tested positive for COVID-19 on 04/02/2023. I contacted my provider and got a prescription for Paxlovid. I tolerated the medication without any complications. As a result of being sick, I lost 8 pounds. As of today, I am feeling better, but I am feeling tired and require a nap.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac stress test, Dyspnoea, Fatigue, Heart rate increased
Clinical narrative: Extreme fatigue Shortness of breath Speech difficulty Elevated pulse rate .....all symptoms since Sept 24th 2021 ...all symptoms still current, but worse
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head, Nasoendoscopy, Speech disorder
Clinical narrative: Extreme fatigue Shortness of breath Speech difficulty Elevated pulse rate .....all symptoms since Sept 24th 2021 ...all symptoms still current, but worse
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Asthenia, Back pain, Blood bilirubin increased, Blood test abnormal
Clinical narrative: Pt. woke up with stomach pains the morning after vaccine, and vomiting, Pt. was very weak and feeling bad for 4 days afterwards  He was told by his doctor to expect this so after 4 days we became more concerned. He vomited off and on for 3 days but was able to eat limited food and drink water throughout the days that followed. He complained of stomach pains, severe back pains and on the Saturday after I took him in to the urgent care. Blood work was done, and the doctor sent him home and told me to bring him back the following Tuesday for repeat blood work. The following week I took him back in to get a follow up blood test to see if his bilirubin and liver enzymes went down.  We received a call to take him to the hospital. He was treated for pancreatitis and spent a week in the hospital and is now in a rehab because he is very weak. He also now has a catheter.
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Catheter placement, Computerised tomogram, Feeling abnormal, Hepatic enzyme increased, Hypophagia
Clinical narrative: Pt. woke up with stomach pains the morning after vaccine, and vomiting, Pt. was very weak and feeling bad for 4 days afterwards  He was told by his doctor to expect this so after 4 days we became more concerned. He vomited off and on for 3 days but was able to eat limited food and drink water throughout the days that followed. He complained of stomach pains, severe back pains and on the Saturday after I took him in to the urgent care. Blood work was done, and the doctor sent him home and told me to bring him back the following Tuesday for repeat blood work. The following week I took him back in to get a follow up blood test to see if his bilirubin and liver enzymes went down.  We received a call to take him to the hospital. He was treated for pancreatitis and spent a week in the hospital and is now in a rehab because he is very weak. He also now has a catheter.
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Magnetic resonance imaging, Pancreatitis, Ultrasound scan, Vomiting
Clinical narrative: Pt. woke up with stomach pains the morning after vaccine, and vomiting, Pt. was very weak and feeling bad for 4 days afterwards  He was told by his doctor to expect this so after 4 days we became more concerned. He vomited off and on for 3 days but was able to eat limited food and drink water throughout the days that followed. He complained of stomach pains, severe back pains and on the Saturday after I took him in to the urgent care. Blood work was done, and the doctor sent him home and told me to bring him back the following Tuesday for repeat blood work. The following week I took him back in to get a follow up blood test to see if his bilirubin and liver enzymes went down.  We received a call to take him to the hospital. He was treated for pancreatitis and spent a week in the hospital and is now in a rehab because he is very weak. He also now has a catheter.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chronic respiratory failure, Condition aggravated, Cystitis, Interstitial lung disease
Clinical narrative: Discharge Provider: DO  Primary Care Provider at Discharge: DO Admission Date: 4/4/2023 Discharge Date: 04/09/2023 Discharge disposition: SAR Condition on discharge: Stable    ADMISSION AND DISCHARGE DIAGNOSES:  HOSPITAL COURSE:   COVID-19 pneumonia. Improving  Chronic Respiratory Failure with Hypoxia and Hypercapnia due to ILD - Per facility, pt tested positive 3/29 and has had symptoms about 7 days - Treated with IV Decadron and IV abx for possible aspiration while inpatient  - Switch to oral Augmenting and Decadron on DC  - On 2L baseline  - Supportive care  - Eliquis for VTE prophylaxis    Not a candidate for Remdesivir due to renal function    Acute Cystitis without Hematuria/urinary incontinence/lethargy  -Treated    Acute Metabolic Encephalopathy  due to above. Resolved    Chronic Combined Congestive Heart Failure NICM CAD s/p CABG Hypertension Pulmonary Hypertension Persistent A-fib/A-flutter s/p MAZE History of DV/PE and LV thrombus -Pt has a CardioMEMS, follows with WM Cardiology -Continue Toprol XL, Aldactone, Demadex, Metolazone, Eliquis and Lipitor    OAB -Can resume Ditropan    Morbid obesity   OSA -Pt does not wear a nightly Cpap -Chronically wears 2 L O2 per NC due to ILD (thought to be caused by Amiodarone use)   DC to SAR